Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03202303 |
|
Recruitment Status :
Recruiting
First Posted : June 28, 2017
Last Update Posted : September 22, 2022
|
Sponsor:
Montefiore Medical Center
Collaborators:
United States Department of Defense
Jazz Pharmaceuticals
Information provided by (Responsible Party):
Montefiore Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 31, 2023 |
| Estimated Study Completion Date : | July 31, 2023 |